Literature DB >> 21087620

Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase.

Natasha C Moningka1, Jennifer M Sasser, Byron Croker, Christy Carter, Chris Baylis.   

Abstract

Age-dependent renal damage is influenced by genetic background and the Fisher344xBrown Norway (F344xBN) rat is resistant to glomerular injury. In vulnerable strains, a fall in renal nitric oxide synthase (NOS) contributes to age-dependent renal damage. Here, we investigated renal NOS in young (3 months) and old (30 months) male F344xBN to test the hypothesis that renal NOS is maintained in "protected" strains. We also examined if 6 months of renin-angiotensin system (RAS) blockade using angiotensin converting enzyme inhibition (ACEI) and angiotensin receptor blockade (ARB) provides further benefit in these "protected" old rats. Aging increased tubulointerstitial injury but glomerular sclerosis was minimal and NOS and superoxide dismutase abundance increased. There was no change in the NOS inhibitor, ADMA (asymmetric dimethylarginine) or its regulatory enzymes. RAS blockade with ARB protected against tubulointerstitial injury and increased nNOSα, but ACEI, which also increased nNOSα, had no protective effect on the tubulointerstitium. We conclude that the glomerular sclerosis-resistant aged male F344xBN rat maintains renal NOS, thus reinforcing our hypothesis that progressive glomerular injury is related to renal NOS deficiency. The tubulointerstitial injury seen with aging is reversed with 6 months of ARB but not ACEI and is not associated with renal NOS.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087620      PMCID: PMC3032044          DOI: 10.1016/j.mad.2010.10.004

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  32 in total

Review 1.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

Review 2.  The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation.

Authors:  Thomas B Nicholson; Taiping Chen; Stéphane Richard
Journal:  Pharmacol Res       Date:  2009-07-28       Impact factor: 7.658

3.  Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.

Authors:  C Berry; J Norrie; J J McMurray
Journal:  Am J Cardiol       Date:  2001-03-01       Impact factor: 2.778

4.  LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases.

Authors:  R H Böger; K Sydow; J Borlak; T Thum; H Lenzen; B Schubert; D Tsikas; S M Bode-Böger
Journal:  Circ Res       Date:  2000-07-21       Impact factor: 17.367

5.  Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats.

Authors:  Y Xiong; L W Yuan; H W Deng; Y J Li; B M Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-10       Impact factor: 2.557

6.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

7.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

8.  Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.

Authors:  M Loredana Marcovecchio; R Neil Dalton; Charles Turner; A Toby Prevost; Barry Widmer; Rakesh Amin; David B Dunger
Journal:  Arch Dis Child       Date:  2009-11-29       Impact factor: 3.791

Review 9.  Telmisartan prevents cardiovascular events in a broad group of at-risk patients.

Authors:  Magnus Baumhäkel; Michael Böhm
Journal:  Expert Opin Pharmacother       Date:  2009-12       Impact factor: 3.889

10.  ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.

Authors:  Christoph Schindler
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-08
View more
  11 in total

1.  Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.

Authors:  Jennifer M Sasser; Natasha C Moningka; Tatsiana Tsarova; Chris Baylis
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

2.  Age-related declines in thirst and salt appetite responses in male Fischer 344×Brown Norway rats.

Authors:  Robert L Thunhorst; Terry Beltz; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2014-06-19

Review 3.  Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia.

Authors:  Christy S Carter; Emanuele Marzetti; Christiaan Leeuwenburgh; Todd Manini; Thomas C Foster; Leanne Groban; Philip J Scarpace; Drake Morgan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-02       Impact factor: 6.053

4.  Sexual dimorphism in development of kidney damage in aging Fischer-344 rats.

Authors:  Jennifer M Sasser; Oladele Akinsiku; Natasha C Moningka; Katie Jerzewski; Chris Baylis; Amanda J LeBlanc; Lori S Kang; Amy L Sindler; Judy M Muller-Delp
Journal:  Gend Med       Date:  2012-07-20

5.  Persistent injury-associated anemia and aging: Novel insights.

Authors:  Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2018-03       Impact factor: 3.313

6.  Persistent injury-associated anemia in aged rats.

Authors:  Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr
Journal:  Exp Gerontol       Date:  2018-01-04       Impact factor: 4.032

7.  Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat.

Authors:  Natasha C Moningka; Amy L Sindler; Judy M Muller-Delp; Chris Baylis
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

Review 8.  Nitric oxide synthase derangements and hypertension in kidney disease.

Authors:  Chris Baylis
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

9.  Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.

Authors:  Ji Min Kim; Hyoung-Sam Heo; Yeon Ja Choi; Byeong Hyeok Ye; Young Mi Ha; Arnold Young Seo; Byung Pal Yu; Christiaan Leeuwenburgh; Hae Young Chung; Christy S Carter
Journal:  Exp Gerontol       Date:  2011-03-03       Impact factor: 4.032

10.  Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.

Authors:  Natasha C Moningka; Tatsiana Tsarova; Jennifer M Sasser; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2011-08-19       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.